Market Cap (In HKD)
590.2 Million
Revenue (In HKD)
565.6 Million
Net Income (In HKD)
-36.27 Million
Avg. Volume
29.37 Thousand
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.75-1.4
- PE
- -
- EPS
- -
- Beta Value
- 0.547
- ISIN
- KYG370981030
- CUSIP
- G37098103
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Zhiming Cao
- Employee Count
- -
- Website
- https://www.fusenyy.com
- Ipo Date
- 2018-07-11
- Details
- Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions, Ganweikang tablets, and Yixinkang tablets. In addition, it researches, develops, produces, and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever, cardiovascular diseases, and anemia. Further, the company offers business management and consulting services. Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang, China.
More Stocks
-
EPSOMPROEpsom Properties Limited
EPSOMPRO
-
CODAFCodan Limited
CODAF
-
TINNATFLTinna Trade Limited
TINNATFL
-
000705
-
HINDWAREAPHindware Home Innovation Limited
HINDWAREAP
-
BTPNPT Bank BTPN Tbk
BTPN
-
BHB
-
3696Ceres Inc.
3696